Cargando…
248. Evaluation of Continuous versus Intermittent Infusion of Nafcillin in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
BACKGROUND: Anti-Staphylococcal penicillins (ASPCN) are first-line agents in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia (MSSA-B), and continuous infusion (CI) of oxacillin was associated with higher rates of 30-day microbiological cure versus intermittent (II) in infec...
Autores principales: | Williamson, Julie E, Wood, Sarah, Carlson, Travis J, Jaffa, Rupal K, Boger, Michael S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678796/ http://dx.doi.org/10.1093/ofid/ofad500.321 |
Ejemplares similares
-
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011) -
1067. Comparative Effectiveness of Nafcillin or Oxacillin, Cefazolin, and Piperacillin/Tazobactam in Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Beganovic, Maya, et al.
Publicado: (2018) -
275. Comparison of Cefazolin versus Nafcillin for Methicillin-Susceptible Staphylococcus aureus Bacteremia with a Deep-Seated Source
por: Mersinger, Katherine E, et al.
Publicado: (2020) -
Genetic Determinants Enabling Medium-Dependent Adaptation to Nafcillin in Methicillin-Resistant Staphylococcus aureus
por: Salazar, Michael J., et al.
Publicado: (2020) -
Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study
por: Oh, Dong Hyun, et al.
Publicado: (2018)